ONYX LIQUID EMBOLIC SYSTEM
FDA premarket approval P030004/S012 · decided 2017-01-25
Approval details
- PMA number
- P030004
- Supplement
- S012
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- ONYX LIQUID EMBOLIC SYSTEM
- Generic name
- Agent, injectable, embolic
- Applicant
- Ev3 Neurovascular
- Date received
- 2016-12-27
- Decision date
- 2017-01-25
- Days to decision
- 29 days
- Decision code
- OK30
- Product code
- MFE
- Advisory committee
- Neurology
- Expedited review
- No
- Location
- Irvine, CA
- Statement
- Acceptance for manufacturing equipment/process changes related to the production of the Onyx Liquid Embolic System (LES), which include addition of an alternative cleaning and de-pyrogenation method for the Onyx LES, addition of an alternative dry heat sterilization oven for the Onyx LES, and change of bioburden testing lab for the Onyx vial subassembly.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| MERIDIAN GUIDEWIRE (K093681) | Ev3 Neurovascular | 2010-01-26 |
| HYPERGLIDE OCCLUSION BALLOON SYSTEM, HYPERFORM OCCLUSION BALLOON SYSTEM, MODEL 104-4112, 104-4113, 104-4127,104-4132,104 (K091458) | Ev3 Neurovascular | 2009-10-15 |
| HYPERGLIDE OCCLUSION BALLOON SYSTEM, MODEL 104-4310, 104-4315 (K092495) | Ev3 Neurovascular | 2009-09-22 |